|
1
|
Banik BK and Becker FF: Synthesis,
electrophilic substitution and structure-activity relationship
studies of polycyclic aromatic compounds towards the development of
anticancer agents. Curr Med Chem. 8:1513–1533. 2001. View Article : Google Scholar
|
|
2
|
Lerman LS: Structural considerations in
interaction of DNA and acridines. J Mol Biol. 3:18–30. 1961.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lerman LS: Structure of DNA-acridine
complex. Proc Natl Acad Sci USA. 49:94–102. 1963. View Article : Google Scholar
|
|
4
|
Brana MF, Cacho M, Gradillas A, de
Pascual-Teresa B and Ramos A: Intercalators as anticancer drugs.
Curr Pharm Des. 7:1745–1780. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Martinez R and Chacon-Garcia L: The search
of DNA- intercalators as antitumoral drugs: what it worked and what
did not work. Curr Med Chem. 12:127–151. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Malonne H and Atassi G: DNA topoisomerase
targeting drugs: mechanisms of action and perspectives. Anticancer
Drugs. 8:811–822. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Banik BK and Becker FF: Polycyclic
aromatic compounds as anticancer agents: structure-activity
relationships of chrysene and pyrene derivatives. Bioorg Med Chem.
9:593–605. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wunz TP, Craven MT, Karol MD, Hill GC and
Remers WA: DNA-binding by antitumor anthracene-derivatives. J Med
Chem. 33:1549–1553. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iyengar BS, Dorr RT, Alberts DS, Solyom
AM, Krutzsch M and Remers WA: 1,4-disubstituted anthracene
antitumor agents. J Med Chem. 40:3734–3738. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dorr RT, Liddil JD, Sami SM, Remers W,
Hersh EM and Alberts DS: Preclinical antitumor activity of the
azonafide series of anthracene-based DNA intercalators. Anticancer
Drugs. 12:213–220. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rescifina A, Chiacchio MA, Corsaro A, De
Clercq E, Iannazzo D, Mastino A, Piperno A, Romeo G, Romeo R and
Valveri V: Synthesis and biological activity of isoxazolidinyl
polycyclic aromatic hydrocarbons: potential DNA intercalators. J
Med Chem. 49:709–715. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kamal A, Ramesh G, Srinivas O and Ramulu
P: Synthesis and antitumour activity of pyrene-linked pyrrolo
[2,1-c][1,4]benzodiazepine hybrids. Bioorg Med Chem Lett.
14:471–474. 2004.PubMed/NCBI
|
|
13
|
Bair KW, Tuttle RL, Knick VC, Cory M and
McKee DD: (1-Pyrenylmethyl) amino alcohols, a new class of
antitumor DNA intercalators – discovery and initial amine
side-chain structure activity studies. J Med Chem. 33:2385–2393.
1990.PubMed/NCBI
|
|
14
|
Bair KW, Andrews CW, Tuttle RL, Knick VC,
Cory M and McKee DD: 2-[(arylmethyl)amino]-2-methyl-1,3-propanediol
DNA intercalators – an examination of the effects of aromatic ring
variation on antitumor-activity and DNA-binding. J Med Chem.
34:1983–1990. 1991.
|
|
15
|
Demeunynck M, Bailly C and Wilson WD: DNA
and RNA Binders. Wiley-VCH. Weinheim: 2002. View Article : Google Scholar
|
|
16
|
De Vita VT, Hellman S and Rosenberg SA:
Cancer: Principles and Practice of Oncology. 6th edition.
Lippincott Williams and Wilkins; Philadelphia, PA: 2001
|
|
17
|
Lown JW: Anthracycline and anthraquinone
anticancer agents: current status and recent developments.
Pharmacol Ther. 60:185–214. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar
|
|
19
|
Banik BK, Basu MK and Becker FF: Novel
disubstituted chrysene as a potent agent against colon cancer.
Oncol Lett. 1:1033–1035. 2010.PubMed/NCBI
|
|
20
|
Banik BK and Becker FF: Novel
6,12-disubstituted chrysene as potent anticancer agent: synthesis,
in vitro and in vivo study. Eur J Med Chem. 45:4687–4691. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Banik BK, Mukhopadhyay C and Becker FF:
Synthesis and biological evaluation of novel dibenzofluorene
derivatives as anticancer agents. Oncol Lett. 1:309–311. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Banik BK, Samajdar S and Becker FF:
Asymmetric synthesis of anticancer β-lactams via Staudinger
reaction. Mol Med Reports. 3:319–321. 2010.
|
|
23
|
Banik BK and Becker FF: Selective
anticancer activity of β-lactams derived from polyaromatic
compound. Mol Med Reports. 3:315–316. 2010.
|
|
24
|
Banik BK, Banik I and Becker FF:
Asymmetric synthesis of anticancer β-lactams via Staudinger
reaction: utilization of chiral ketene from carbohydrate. Eur J Med
Chem. 45:846–848. 2010.
|
|
25
|
Banik BK, Banik I and Becker FF:
Stereocontrolled synthesis of anticancer β-lactams via the
Staudinger reaction. Biorg Med Chem. 13:3611–3622. 2005.
|
|
26
|
Banik BK, Becker FF and Banik I: Synthesis
of anticancer β-lactams: mechanism of action. Biorg Med Chem.
12:2523–2528. 2004.
|
|
27
|
Banik I, Becker FF and Banik BK:
Stereoselective synthesis of β-lactams with polyaromatic imines:
entry to new and novel anticancer agents. J Med Chem. 46:12–15.
2003.
|
|
28
|
Becker FF, Mukhopadhyay C, Hackfeld L,
Banik I and Banik BK: Polycyclic aromatic compounds as anticancer
agents: synthesis and biological evaluation of dibenzofluorene
derivatives. Bioorg Med Chem. 8:2693–2699. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Becker FF and Banik BK: Polycyclic
aromatic compounds as anticancer agents: synthesis and biological
evaluation of some chrysene derivatives. Biorg Med Chem Lett.
8:2877–2880. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vichai V and Kirtikara K: Sulforhodamine B
colorimetric assay for cytotoxicity screening. Nat Protoc.
1:1112–1116. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Búcsiová L, Hrdlovič P and Chmela S:
Spectral characteristics of fluorescence probes based on pyrene in
solution and in polymer matrices. J Photochem Photobiol A Chem.
143:59–68. 2001.
|
|
32
|
Hrdlovič P and Chmela S: Spectral
characteristics of probes based on ionic derivatives of pyrene in
polar polymer matrices. J Photochem Photobiol A Chem. 118:137–142.
1998.
|
|
33
|
Spiro M, Vigny P and Hodgson RM:
Fluorescence spectral studies on the metabolic activation of
chrysene by hamster embryo cells. Carcinogenesis. 3:1491–1493.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ohara K, Smietana M, Restouin A, Mollard
S, Borg J, Collette Y and Vasseur J: Amine-guanidine switch: a
promising approach to improve DNA binding and antiproliferative
activities. J Med Chem. 50:6465–6475. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Landis-Piwowar KR, Chen D, Cui QC, Minic
V, Becker FF, Banik BK and Dou QP: Apoptotic-inducing activity of
novel polyaromatic compounds in human leukemic cells. Int J Mol
Med. 17:931–935. 2006.PubMed/NCBI
|
